Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania's Ministry of Finance has raised approximately €4.7 billion from international financial markets through the country's first external bond issuance of 2026.
Patria Bank has signed a contract to sell its 99.9% stake in SAI Patria Asset Management to BRD Asset Management SAI for €5.5 million.
The current conflict in Iran may only have a marginal impact on the global economy, according to an opinion by stock exchange broker Investimental.
Romania continues to lag significantly behind the European average regarding the modernisation of its rail infrastructure.
Romania's Ministry of Finance has announced a new spring edition of its Tezaur government bond programme, offering citizens attractive investment opportunities with annual interest rates reaching 7%.